Virpax Pharmaceuticals Inc (VRPX)
2.29
-0.25
(-9.84%)
USD |
NASDAQ |
May 02, 16:00
2.29
0.00 (0.00%)
After-Hours: 16:31
Virpax Pharmaceuticals Market Cap: 2.682M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.975M |
| April 30, 2024 | 3.104M |
| April 29, 2024 | 3.244M |
| April 26, 2024 | 3.631M |
| April 25, 2024 | 3.418M |
| April 24, 2024 | 3.713M |
| April 23, 2024 | 3.701M |
| April 22, 2024 | 3.865M |
| April 19, 2024 | 4.310M |
| April 18, 2024 | 4.732M |
| April 17, 2024 | 4.064M |
| April 16, 2024 | 4.064M |
| April 15, 2024 | 4.135M |
| April 12, 2024 | 4.158M |
| April 11, 2024 | 4.228M |
| April 10, 2024 | 4.287M |
| April 09, 2024 | 4.111M |
| April 08, 2024 | 4.392M |
| April 05, 2024 | 4.556M |
| April 04, 2024 | 4.790M |
| April 03, 2024 | 4.872M |
| April 02, 2024 | 4.884M |
| April 01, 2024 | 4.931M |
| March 28, 2024 | 4.991M |
| March 27, 2024 | 4.415M |
| Date | Value |
|---|---|
| March 26, 2024 | 4.544M |
| March 25, 2024 | 4.458M |
| March 22, 2024 | 4.720M |
| March 21, 2024 | 4.849M |
| March 20, 2024 | 5.137M |
| March 19, 2024 | 4.890M |
| March 18, 2024 | 4.369M |
| March 15, 2024 | 4.883M |
| March 14, 2024 | 4.532M |
| March 13, 2024 | 4.117M |
| March 12, 2024 | 4.708M |
| March 11, 2024 | 5.797M |
| March 08, 2024 | 5.306M |
| March 07, 2024 | 4.954M |
| March 06, 2024 | 4.661M |
| March 05, 2024 | 5.036M |
| March 04, 2024 | 4.410M |
| March 01, 2024 | 4.111M |
| February 29, 2024 | 3.574M |
| February 28, 2024 | 3.719M |
| February 27, 2024 | 3.40M |
| February 26, 2024 | 3.981M |
| February 23, 2024 | 3.959M |
| February 22, 2024 | 3.633M |
| February 21, 2024 | 3.514M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.682M
Minimum
May 02 2024
113.58M
Maximum
Aug 18 2021
19.34M
Average
14.00M
Median
Market Cap Benchmarks
| Sorrento Therapeutics Inc | 7.718M |
| Scilex Holding Co | 90.56M |
| Coya Therapeutics Inc | 127.77M |
| CEL-SCI Corp | 79.89M |
| AIM ImmunoTech Inc | 20.13M |
Market Cap Related Metrics
| Price to Book Value | 1.387 |
| Price | 2.29 |
| Earnings Yield | -566.4% |